venBio Global Strategic Fund III, L.P.

Artiva Biotherapeutics, Inc. · 10% Owner

venBio Global Strategic Fund III, L.P. is listed in public filings as 10 percent owner. This venBio Global Strategic Fund III, L.P. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Artiva Biotherapeutics, Inc. (ARTV). Investors use venBio Global Strategic Fund III, L.P.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Artiva Biotherapeutics, Inc.ARTV$5.0M416.7k sharesBuyJul 22, 2024$12.00--